Iron chelation therapy

Journal of Internal Medicine, Supplement

Volumn 242, Issue 740, 1997, Pages 37-41

  Hoffbrand, A V ^a  

^a ROYAL FREE HOSPITAL   (United Kingdom)

Author keywords

Deferiprone; Desferrioxamine; Iron chelation; Thalassaemia major

Indexed keywords

DEFERIPRONE; DEFEROXAMINE; FERRITIN; IRON CHELATING AGENT; PYRIDONE DERIVATIVE;

AGRANULOCYTOSIS; ARTHROPATHY; CARDIOMYOPATHY; CONFERENCE PAPER; DEATH; DIGESTIVE SYSTEM FUNCTION DISORDER; DRUG SAFETY; FERRITIN BLOOD LEVEL; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; IRON CHELATION; IRON OVERLOAD; IRON STORAGE; LIVER BIOPSY; MYELODYSPLASIA; NEUTROPENIA; ORAL DRUG ADMINISTRATION; PATIENT COMPLIANCE; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; THALASSEMIA MAJOR; ZINC DEFICIENCY; REVIEW;

DEFEROXAMINE; HUMANS; IRON CHELATING AGENTS; PYRIDONES;

EID: 0030883704     PISSN: 09557873     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (1)

1. Olivieri NF. Brittenham GM. Iron-chelating therapy and the treatment of thalassemia. Blood 1997; 89:739-61.